专利号:US-2011040105-A1 优先权日:2008-04-16 标题 :Processes useful for the synthesis of (r)-1--2-methyl-pyrrolidine 发明人:HUBER CHRISTIAN H; KHULMAN YOUNG MI; TANDEL SAGUN K; JOHANNSEN STEPHEN R; WANG TINGMIN; ANGELL PAUL 权利人:ARENA PHARM INC 摘要:Processes useful for making a pharmaceutically useful compound according to Formula (I), forms of such a compound, and intermediates useful in such processes are described.
专利号:US-7547436-B2 优先权日:1995-01-17 标 题:Receptor specific transepithelial transport of therapeutics 发明人:BLUMBERG RICHARD S; LENCER WAYNE I; SIMISTER NEIL E 权利人:BRIGHAM & WOMENS HOSPITAL; UNIV BRANDEIS 摘要:The present invention relates in general to methods and products for initiating an immune response against an antigen, and in particular relates to transepithelial delivery of antigens to provoke tolerance and immunity. The present invention further relates to methods and products for the transepithelial delivery of therapeutics. In particular, the invention relates to methods and compositions for the delivery of therapeutics conjugated to a FcRn binding partner to intestinal epithelium, mucosal epithelium and epithelium of the lung. The present invention further relates to the synthesis, preparation and use of the FcRn binding partner conjugates as, or in, pharmaceutical compositions for oral systemic delivery of drugs and vaccines.
专利号:US-9751877-B2 优先权日:2012-09-21 标题 :Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders 发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; PATEL NANDINI CHATURBHAI; STIFF CORY MICHAEL; TRAN TUAN PHONG; KAUFFMAN GREGORY WAYNE; STEPAN ANTONIA FRIEDERIKE; VERHOEST PATRICK ROBERT 权利人:PFIZER 摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
专利号:US-8945508-B2 优先权日:2009-10-13 标 题 :Dendrimer compositions and methods of synthesis 发明人:BAKER JR JAMES R; HUANG BAOHUA 权利人:BAKER JR JAMES R; HUANG BAOHUA; UNIV MICHIGAN 摘要:The present invention relates to novel dendrimer compounds and methods of synthesizing the same. In particular, the present invention is directed to novel polyamidoamine (PAMAM) dendrimers, novel dendrimer branching units, methods for synthesizing such novel PAMAM dendrimers and functionalized dendrimers, as well as systems and methods utilizing the dendrimers (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease diagnosis and/or therapy, etc.))).
专利号:CN-102066319-A 优先权日:2008-04-16 标 题 :Processes useful for the synthesis of (R)-1-{2-[4'-(3-methoxypropane-1-sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine
专利号:EP-2282992-A1 优先权日:2008-04-16 标 题 :Processes useful for the synthesis of (r)-1-{2-ý4'-(3-methoxypropane-1-sulfonyl)-biphenyl-4-yl¨-ethyl}-2-methyl-pyrrolidine
Wośko S, Serefko A, Szopa A, Kardaś S, Widelski J, Mroczek T, Rostkowska E, Szymańska J, Poleszak E. Influence of Smallanthus sonchifolius (Yacon) on the Activity of Antidepressant Drugs in Mice. Life (Basel). 2021 Oct 21;11(11):1117. doi: 10.3390/life11111117. Sołek P, Mytych J, Tabęcka-Łonczyńska A, Koziorowski M. Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects. Int J Mol Sci. 2021 Nov 1;22(21):11855. doi: 10.3390/ijms222111855. 1: Mergui J, Jaworowski S. Risperidone-Induced Nocturnal Enuresis Successfully Treated With Reboxetine. Clin Neuropharmacol. 2016 Mar 17. [Epub ahead of print] doi: 10.1016/j.pbb.2016.02.005. Epub 2016 Feb 15. doi: 10.1038/npp.2015.194. Epub 2015 Jul 1. doi: 10.1089/cap.2015.0199. Epub 2016 Jan 27. doi: 10.1016/j.pbb.2015.10.006. Epub 2015 Oct 9. doi: 10.1016/j.pharep.2015.04.016. Epub 2015 May 9. doi: 10.1136/bmj.h5842. doi: 10.1177/1550059414532443. Epub 2014 Sep 24. doi: 10.18097/PBMC20156105657. Russian. pii: pyv080. doi: 10.1093/ijnp/pyv080. 11: Ghanizadeh A. A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder. Nord J Psychiatry. 2015 May;69(4):241-8. doi: 10.3109/08039488.2014.972975. Epub 2014 Nov 21. Review. doi: 10.1038/nsmb.3029. Epub 2015 May 11. 13: Yucel A, Yucel N, Ozcan H, Gulec M, Aydin A. Fluoxetine associated with thrombocytopenia and treatment with reboxetine: 3 cases. J Clin Psychopharmacol. 2015 Jun;35(3):354-5. doi: 10.1097/JCP.0000000000000301. doi: 10.1016/j.bbr.2014.12.023. Epub 2014 Dec 16. doi: 10.1097/01.j.pain.0000460313.73358.31. doi: 10.1002/jnr.23473. Epub 2014 Aug 21. doi: 10.1017/S0033291714000221. Epub 2014 Mar 3.
合成参考文献
参考文献:10.2165/11530130-000000000-00000 摘要:Hasnain M, Vieweg WV, Fredrickson SK. Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions. CNS Drugs. 2010 Mar;24(3):193–206. doi: 10.2165/11530130-000000000-00000. 参考文献:10.1007/s11940-011-0137-6 摘要:Hirai N, Nishino S. Recent advances in the treatment of narcolepsy. Curr Treat Options Neurol. 2011 Oct;13(5):437–57. doi: 10.1007/s11940-011-0137-6. 参考文献:10.2165/11592040-000000000-00000 摘要:Cheung BM. Drug treatment for obesity in the post-sibutramine era. Drug Saf. 2011 Aug 01;34(8):641–50. doi: 10.2165/11592040-000000000-00000. 参考文献:10.1007/s00213-011-2413-2 摘要:Wing VC, Shoaib M. Translating the smoking cessation properties of the antidepressant nortriptyline using reinforcing, discriminative and aversive stimulus effects of nicotine in rats. Psychopharmacology (Berl). 2012 Feb;219(3):847–57. doi: 10.1007/s00213-011-2413-2. 参考文献:10.1007/s10549-005-9056-0 摘要:Chien C, Li CI, Heckbert SR, Malone KE, Boudreau DM, Daling JR. Antidepressant use and breast cancer risk. Breast Cancer Research and Treatment. 2005 Dec 02;95(2):131–40. doi: 10.1007/s10549-005-9056-0.